Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98.7M
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
134M
-
Shares change
-
-2.67M
-
Total reported value, excl. options
-
$738M
-
Value change
-
-$18.2M
-
Put/Call ratio
-
0.53
-
Number of buys
-
63
-
Number of sells
-
-75
-
Price
-
$5.52
Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q2 2023
185 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q2 2023.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 134M shares
.
Largest 10 shareholders include Francisco Partners Management, LP (84.7M shares), VANGUARD GROUP INC (8.5M shares), Silver Lake Group, L.L.C. (3.53M shares), Petrus Trust Company, LTA (2.9M shares), RENAISSANCE TECHNOLOGIES LLC (2.5M shares), MILLENNIUM MANAGEMENT LLC (2.18M shares), BlackRock Inc. (2.04M shares), ORBIMED ADVISORS LLC (1.79M shares), Technology Crossover Management X, Ltd. (1.65M shares), and MORGAN STANLEY (1.44M shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.